SCHEMBL8173575

SCHEMBL8173575

CN1C(=O)[C@@H](O)[C@@H](c2ccccc2)[C@H]1C(=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.39
MAPT P10636 5/20 0.38
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
KDM4E B2RXH2 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
HIF1A Q16665 1/20 0.38
HTT P42858 3/20 0.38
LMNA P02545 2/20 0.38
PKM P14618 1/20 0.38
HDAC4 P56524 3/20 0.37
HDAC3 O15379 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
HDAC9 Q9UKV0 2/20 0.37
HDAC5 Q9UQL6 2/20 0.37
ALOX15 P16050 1/20 0.37
HBB P68871 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8509434 1.00 EPHX1 (0.39) EPHX1MAPTMEN1KMT2AKDM4E
SCHEMBL6837215 1.00 EPHX1 (0.39) EPHX1MAPTMEN1KMT2AKDM4E
SCHEMBL9679048 1.00 EPHX1 (0.39) EPHX1MAPTMEN1KMT2AKDM4E
SCHEMBL8508684 1.00 EPHX1 (0.39) EPHX1MAPTMEN1KMT2AKDM4E
SCHEMBL8168467 1.00 EPHX1 (0.39) EPHX1MAPTMEN1KMT2AKDM4E
SCHEMBL6837104 1.00 EPHX1 (0.39) EPHX1MAPTMEN1KMT2AKDM4E
SCHEMBL8169250 0.85 MAPT (0.41) EPHX1MAPTMEN1KMT2AKDM4E
SCHEMBL8161726 0.85 MAPT (0.41) EPHX1MAPTMEN1KMT2AKDM4E
SCHEMBL8408205 0.77 KMT2A (0.40) MEN1KMT2AHDAC4HDAC3HDAC7
SCHEMBL9680139 0.72 EPHX1 (0.41) EPHX1MAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030207935-A1 Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES 2003-11-06 US disclosed
US-20030207935-A1 Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES 2003-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207935-A1 Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use HIF1AN, HIF1A, CLN6 EPHX1 455/4885MAPT 59/4885MEN1 2195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.